NCT02188953View on ClinicalTrials.gov

Evaluation of ACCS100 to Reduce Aflatoxin Exposure in Kenya

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Aflatoxicosis
Interventions
DRUG

ACCS100

ACCS100 is made from Hydrated Sodium Calcium Aluminosilicate, which is a substance generally recognized as safe by the U.S. FDA.

DRUG

Calcium carbonate placebo

Trial Locations (1)

Unknown

Makindu Health Center, Makindu

Sponsors
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Texas A&M University

OTHER

collaborator

Kenya Ministry of Health

OTHER_GOV

lead

Kenya Medical Research Institute

OTHER